Absolutely essential talk by Robert Wilson CSI Congress on Radiation Exposure!! We need to do better—can societies help? Will hospital administration support? American Society of Echocardiography SCAI American College of Cardiology European Society of Cardiology EACVI President

Can a Clinical Decision Support System Redress Institutional Racial Inequities?? Find out here! catalyst.nejm.org/doi/full/10.10… Penn Cardiology Penn LDI michellemorse Brigham and Women's Hospital Mass General Brigham

Agenda now live! Take a look and register for the fellows bootcamp! Babar Basir Suzanne J. Baron MD MSc Jason N. Katz Felix Yang, MD, FACC, FHRS Anu Lala-Trindade Triston B.B.J. Smith MD MGM FSCAI Sahil Khera Kelly Arps, MD Luigi Di Biase Carlos L. Alviar MD, FACC Ann Gage Anna Bortnick MD, PhD, MSc Rama Ellauzi xavier prida Ivan Chevere MIЯVΛƬ #IC

Right heart catheterization in heart failure: indications, interpretation, and pitfalls academic.oup.com/eurheartj/adva… #CardioEd #EHJ European Society of Cardiology Journals European Society of Cardiology

🔍 Thrombophilia testing? Knowing when and how to test is crucial — but so is knowing which lab to trust. The latest ISTH SSC guidance outlines best practices and recommendations for lab selection and testing reliability. Read it👇Share it Apply it #ISTH2025 #Hemostasis

Timing initiating #heparin crucial in #pulmonary embolism mortality #ISTH2025 ⁦Vasculearn Network⁩ ⁦The PERT Consortium®⁩ ⁦Anticoagulation Forum⁩ ⁦Thrombosis Canada⁩ ⁦World Thrombosis Day⁩ ⁦CanVECTOR Network⁩ ⁦European Thrombosis & Haemostasis Alliance (ETHA)⁩ ⁦Medscape⁩ ⁦Thrombosis UK⁩

Is this the end of rivaroxaban for acute VTE? Lana Castellucci presenting the COBBRA trial - 1st RCT comparing apixaban to riva over 3 months. 56% reduction in bleeding risk with apixaban. A safer Rx with the same efficacy. #ISTH2025

Wonderful work led by Ahmad Jabri MD , FACC, FSCAI describing the use of #SCAISHOCKStages in pts w/ PE. Srihari S. Naidu, MD Navin Kapur Jay Giri Sripal Bangalore herbaronowMD Vikas Aggarwal Link: sciencedirect.com/science/articl…

Unhealthy weight has been linked to 60+ conditions, including heart risk factors, #CVD, #cvMI and #Stroke. Download the latest #CardioSmart infographic supporting the ACC’s new Concise Clinical Guidance on medical weight management. Learn more: bit.ly/4kOqGkx

🩸 New insights from the RENOVE trial (extended duration anticoagulation) at #ISTH2025: 📉 Reduced-dose DOAC is non-inferior in patients with BMI <30, with less bleeding risk. ⚠️ But in patients with BMI ≥30, reduced-dose may be inferior for bleeding and recurrent VTE. ➡️

No change in post-thrombotic syndrome indices or stent thrombosis with #DOAC vs #DOAC + ASA after venous stent: ARIVA trial ⁦Vasculearn Network⁩ ⁦Anticoagulation Forum⁩ ⁦The PERT Consortium®⁩ ⁦Thrombosis Canada⁩ ⁦Thrombosis UK⁩ ⁦CanVECTOR Network⁩ ⁦European Thrombosis & Haemostasis Alliance (ETHA)⁩

ARIVA trial compared 6mo riva vs riva + ASA after venous stent for PTS. ♥️ No difference in patency 💙 No difference in PTS symptoms ♥️ Patency rate was 94% at 6 months - much higher than expected 💙 Trial stopped early for futility Published in Circulation in March #ISTH2025

🔴Pulmonary Hypertension: Updates in Diagnosis and Management⤵️ #2025commentary #openaccess 🔹mdpi.com/2077-0383/14/7… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX

With echo boards coming up how about some Echo Hemodynamics?? ❤️Here is a great resource for all you studying for echo boards on common hemodynamic equations used in echocardiography. One of my favorite parts of echo is the amount of hemodynamic data you can obtain non

Acetylcholine provocation testing. How does dosing affect the diagnostic performance in the detection of coronary spasm in ANOCA? Rajan Rehan #Cardiotwitter #AHAJournals ahajrnls.org/44ALvKs

This great #coronaryDissection paper addressing #CoronaryDCB on #DenovoLesions mirrors #PeripheralDCB outcomes in #PVI 💎#NoDCB without #CoronaryImaging Gotta love it when things make sense in our growing #CVinterventionalField !

Renal denervation for HTN was approved the FDA over 18 months ago. But very few cases performed in the US despite a theoretical eligible population >100M patients for this therapy. We cover the elephant in the room: reimbursement in Cardiac Interventions Today. citoday.com/articles/2025-…

Thinking about a career in vascular medicine? It’s one of the most exciting—and evolving—fields in cardiology. Join American College of Cardiology on August 4th for a webinar: “Navigating Career Pathways in Vascular Medicine". 🔗 hubs.la/Q03xy6Jy0 #VascularMedicine #CardiologyCareers

Join us for the upcoming webinar “Navigating Career Pathways in Vascular Medicine” hosted by American College of Cardiology American College of Cardiology in collaboration with Society of Vascular Medicine Society for Vascular Medicine | SVM August 4th, 7 pm EST. Learn more & Register here: bit.ly/44nhcXS

Amazing job Nichole Brunton, DO leading a comprehensive review on #IntermediateRiskPE! A must read for all #PE enthusiasts. Dinu V. Balanescu, M.D. Mayo Clinic CV Michael Young Eric Secemsky MD MSc Society for Vascular Medicine | SVM American College of Cardiology